SEC Filings for TG Therapeutics Inc. (TGTX)

$ 18.28   0.69 (+3.92%) Volume: 2.94m 4:00 PM EDT 5-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
PX14A6GNotice of exempt solicitation submitted by non-management105/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)6005/18/2020
424B5Prospectus [Rule 424(b)(5)]9605/18/2020
424B5Prospectus [Rule 424(b)(5)]9505/14/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)9905/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)905/11/2020
3Initial statement of beneficial ownership of securities105/07/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)704/30/2020
DEF 14AOther definitive proxy statements4404/29/2020
DEFA14AAdditional proxy soliciting materials - definitive604/29/2020
424B5Prospectus [Rule 424(b)(5)]3503/20/2020
8-KCurrent report pursuant to Section 13 or 15(d)4503/20/2020
8-KCurrent report pursuant to Section 13 or 15(d)1003/03/2020
10-KAnnual report pursuant to Section 13 or 15(d)14203/02/2020
<<
First
<
Prev
123456789101112131415